| pubmed-article:7905253 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7905253 | lifeskim:mentions | umls-concept:C0242643 | lld:lifeskim |
| pubmed-article:7905253 | lifeskim:mentions | umls-concept:C0280100 | lld:lifeskim |
| pubmed-article:7905253 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:7905253 | lifeskim:mentions | umls-concept:C0016263 | lld:lifeskim |
| pubmed-article:7905253 | pubmed:issue | 6A | lld:pubmed |
| pubmed-article:7905253 | pubmed:dateCreated | 1994-2-28 | lld:pubmed |
| pubmed-article:7905253 | pubmed:abstractText | P-glycoprotein (P-gp) detection by FCM (flow cytometry) was correlated with P-gp detection by immunohistochemical staining or Western blotting in K562 cell lines variably resistant to doxorubicin (DOX). A strong correlation was noted between the flow cytometric data and the degree of resistance assessed by thymidine incorporation assay (TIA). Of the human carcinomas tested, 37.5% were P-gp positive by flow cytometry. The flow cytometry data correlated strongly with the immunohistochemical staining (p < 0.001). Thirteen of the 15 P-gp positive tumors were resistant to DOX and vincristine (VCR) on TIA. Thus, P-gp detection by FCM correlates strongly with tumor sensitivity to DOX and VCR (p < 0.001). | lld:pubmed |
| pubmed-article:7905253 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7905253 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7905253 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7905253 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7905253 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7905253 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7905253 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7905253 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7905253 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7905253 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7905253 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7905253 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:7905253 | pubmed:author | pubmed-author:FujiiHH | lld:pubmed |
| pubmed-article:7905253 | pubmed:author | pubmed-author:TanakaTT | lld:pubmed |
| pubmed-article:7905253 | pubmed:author | pubmed-author:TanigawaNN | lld:pubmed |
| pubmed-article:7905253 | pubmed:author | pubmed-author:MuraokaRR | lld:pubmed |
| pubmed-article:7905253 | pubmed:author | pubmed-author:ShimomatsuyaT... | lld:pubmed |
| pubmed-article:7905253 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7905253 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:7905253 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7905253 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7905253 | pubmed:pagination | 2171-5 | lld:pubmed |
| pubmed-article:7905253 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:meshHeading | pubmed-meshheading:7905253-... | lld:pubmed |
| pubmed-article:7905253 | pubmed:articleTitle | Detection of P-glycoprotein in solid tumors by flow cytometry. | lld:pubmed |
| pubmed-article:7905253 | pubmed:affiliation | Second Department of Surgery, Fukui Medical School, Japan. | lld:pubmed |
| pubmed-article:7905253 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7905253 | lld:pubmed |
